MTEX

Business Context and Reporting Period

Mannatech, Inc. (MTEX) is a global wellness solution provider developing and selling nutritional supplements, skin care, and weight-management products through a network marketing model. This Form 10-Q covers the quarterly period ended June 30, 2024. The Company operates in three regions: the Americas, EMEA, and Asia/Pacific. During the quarter, the Company liquidated its entity in Sweden.

Key Financial Metrics

Note: Cash equivalents include restricted cash. Total debt increased significantly in Q2 2024 due to new related-party borrowings.

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 14.9% in Q2 and 14.4% YTD compared to 2023. On a constant dollar basis, the decline was 12.9% (Q2) and 12.1% (YTD). The decrease was driven by supply chain constraints, back-ordered items, and weakening economic conditions in Asia.
• Regional Performance: Asia/Pacific sales dropped 17.6% in Q2, largely due to a deferred product promotion in Korea caused by supply chain issues. Americas sales fell 10.4%, while EMEA sales declined 14.8%.
• Profitability Improvement: Despite lower revenue, the Net Loss narrowed significantly in Q2 (from $1.1M to $0.6M) and the Company returned to Net Income for the YTD period ($0.6M vs. a $0.5M loss in 2023). This was aided by a $1.4M reduction in payroll and $1.3M reduction in consulting fees.
• Debt Financing: In April 2024, the Company issued $3.6 million in unsecured notes to three Board members (related parties) at 16% interest to fund working capital and technology investments.
• Foreign Exchange: A strengthening U.S. Dollar resulted in foreign exchange gains of $1.1 million in Q2 and $2.0 million YTD, significantly impacting the bottom line.

Outlook, Risks, and Management Commentary

• Management Strategy: Management is executing a 2024 business reorganization plan focusing on revenue growth, margin improvement (including potential price increases), and cost control. They aim to reduce fixed selling and administrative overhead.
• Liquidity: Management believes existing cash and operating cash flows are adequate to fund operations for the next 12 months. However, they noted that if reorganization plans fail or supply chain disruptions persist, they may need to raise additional funds.
• Risks: Key risks include continued supply chain constraints, the impact of foreign currency fluctuations, the ability to attract and retain independent associates, and regulatory changes in international markets (specifically China).
• Unusual Items: The Q2 results included a one-time gain of $0.2 million from the liquidation of the Swedish entity. The effective tax rate was volatile (negative 277.4% in Q2) due to the mix of earnings across jurisdictions and valuation allowances.

Investor Verification Checklist

• Debt Covenants & Interest: Verify the impact of the new $3.6 million related-party debt carrying 16% interest on future cash flows and interest expense.
• Supply Chain Resolution: Confirm if the supply chain constraints and back-orders in Asia/Pacific (specifically Korea) have been resolved to support the deferred product promotion.
• Associate Retention: Monitor the trend of active independent associates, as revenue per associate has declined significantly (19.2% in Asia/Pacific Q2) despite a slight increase in total associate count.
• Foreign Exchange Exposure: Assess the sustainability of the foreign exchange gains; a reversal in currency trends could materially impact future earnings.
• Inventory Levels: Review inventory turnover and obsolescence reserves, as inventory balances remain elevated ($13.2M) relative to sales declines.